September 11, 2017 / 8:33 PM / 10 months ago

CORRECTED-Teva to sell its contraceptive brand Paragard in $1.1 bln deal

(Corrects first paragraph to say the sale was to a unit of Cooper Cos)

Sept 11 (Reuters) - Teva Pharmaceutical Industries , said it has agreed to sell Paragard, its intrauterine copper contraceptive brand, to a unit of Cooper Cos in a $1.1 billion cash deal.

The sale of the business is the first step in the planned divestment of non-core assets, Teva said on Monday.

The deal includes the drug maker's manufacturing facility in Buffalo, NY, which produces Paragard exclusively.

The deal comes on a day when Teva named smaller peer Lundbeck's Kare Schultz as its new chief executive and amid plans for more divestitures. (Reporting by Shailesh Kuber; Editing by Arun Koyyur)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below